Paliperidone: A new atypical antipsychotic or more of the same?

Judy Hope; Nicholas Keks

Paliperidone: A new atypical antipsychotic or more of the same?

Judy Hope, Nicholas Keks

Psychiatry Monash Health

Research output: Contribution to journal › Short Survey › Other › peer-review

Abstract

Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

Original language	English
Pages (from-to)	68-69
Number of pages	2
Journal	Medicine Today
Volume	10
Issue number	7
Publication status	Published - Jul 2009

Cite this

@article{e67e48e9930b433687586032655d01ea,

title = "Paliperidone: A new atypical antipsychotic or more of the same?",

abstract = "Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.",

author = "Judy Hope and Nicholas Keks",

year = "2009",

month = jul,

language = "English",

volume = "10",

pages = "68--69",

journal = "Medicine Today",

issn = "1443-430X",

publisher = "Medicine Today",

number = "7",

}

TY - JOUR

T1 - Paliperidone

T2 - A new atypical antipsychotic or more of the same?

AU - Hope, Judy

AU - Keks, Nicholas

PY - 2009/7

Y1 - 2009/7

N2 - Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

AB - Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

UR - http://www.scopus.com/inward/record.url?scp=68249103843&partnerID=8YFLogxK

M3 - Short Survey

AN - SCOPUS:68249103843

SN - 1443-430X

VL - 10

SP - 68

EP - 69

JO - Medicine Today

JF - Medicine Today

IS - 7

ER -

Paliperidone: A new atypical antipsychotic or more of the same?

Abstract

Other files and links

Cite this